Company Overview

Update
Founded:
2012
Headquarters:
Richmond, VA
Funding:
$2.1M
Categories:
Biotechnology
Description:
Neurotracks is a company that develops tools that enable physicians to predict Alzheimer’s disease before the symptoms appear.

Detailed Description

Update

Neurotrack's technology can diagnose Alzheimer’s Disease up to six years before symptoms occur. Based on ground-breaking research, it enables pharmaceutical companies and researchers to recruit qualified candidates for clinical trials, and more effectively measure drug efficacy, speeding up drug discovery and development.

Neurotrack is also becoming the standard for early clinical screening of Alzheimer’s and dementia related disorders.

Funding Rounds (2) - $2.1M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    4200 Grove Avenue

    Richmond, VA 23221

    USA

Images (1)

Update
  • Edd7d61008d3f1411e6a95911af7af5a